| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/12/2006 | CN1250711C Purging of cells using viruses |
| 04/12/2006 | CN1250572C Anti-body capable to selectively detect prion PrPsc isoforms |
| 04/12/2006 | CN1250571C Specific binding molecules for scintigraphy, conjugates containing them and uses |
| 04/12/2006 | CN1250570C Binding molecules derived from immunolobulins which do not trigger complement mediated lysis |
| 04/12/2006 | CN1250288C Beta glycan as an inhibin receptor and uses thereof |
| 04/12/2006 | CN1250287C Application of recombinant adenovirus in treating cerebral ischemia, traumatic restoration and tissue adhesion |
| 04/12/2006 | CN1250286C Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis |
| 04/12/2006 | CN1250285C Cellular vesicle called 'exosome', prepn. and use thereof in immune stimulation |
| 04/11/2006 | US7026467 High resolution typing system for pathogenic Mycobaterium tuberculosum |
| 04/11/2006 | US7026465 Fusion proteins of Mycobacterium tuberculosis |
| 04/11/2006 | US7026457 Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use |
| 04/11/2006 | US7026456 p75 heterodimer specific anti-human Interleukin-12 (IL-12) antibodies that are characterized by higher potency and greater efficacy in neutralizing human IL-12 bioactivity than known heterodimer specific IL-12 monoclonal antibodies; use treating autoimmune disorders |
| 04/11/2006 | US7026454 Polypeptide of given sequence that is a biochemical marker for prostate cancer conjugated to an antibody or fragment thereof; treating prostate cancer |
| 04/11/2006 | US7026447 53 human secreted proteins |
| 04/11/2006 | US7026443 Composition including an oligopeptide 13 residues or less in length, which comprises the sequence ATLERTEVY (SEQ ID NO:31040); use in epitope-based vaccines |
| 04/11/2006 | US7026330 Administering mixtures of rapamycin and/or derivatives and interleukin antagonists, for prophylaxis of blood disorders; anticarcinogenic agents |
| 04/11/2006 | US7026300 One step immunization procedure for inducing a Chlamydia specific immune response |
| 04/11/2006 | US7026283 Calcium-independent negative regulation by CD81 of receptor signalling |
| 04/11/2006 | US7026161 Lactobacillus sp. strain and use thereof |
| 04/11/2006 | US7026157 Bacterial hemoglobin receptor genes |
| 04/11/2006 | US7026155 Reducing microorganismal propagation; obtain bacteria, methylate nucleotide sequences, incubate with bactericide, monitor propagation microoganisms |
| 04/11/2006 | US7026128 Nucleotide sequences coding polypeptide for use as diagnostic tool in the detection of allergic response to mammalian animal dander |
| 04/11/2006 | US7026113 Veterinary medicine; vaccine containing mutant gene |
| 04/11/2006 | US7025972 Smectite clay intercalated with an organic surface modifier intercalant molecule that contains at least one moiety selected from aldehyde, ketone, carboxylic acid, alcohol, phenol, ether, catecol, lactam, lactone and purrolidone |
| 04/11/2006 | US7025971 By interacting with periplasmic molecular chaperones so the assemlbly of pili is prevented or inhibited and thereby the infectivity of the bacteria is diminished; used in drug design |
| 04/11/2006 | US7025970 Modified poxviruses, including modified smallpox virus vaccine based on recombinant drug-sensitive vaccinia virus, and new selection methods |
| 04/11/2006 | US7025969 Cells activated with cytomegalo virus; vaccine; gene therapy |
| 04/11/2006 | US7025968 Identifying viricidal agents which prevent cytomegalo viral infection and distribution; gene expression inhibition |
| 04/11/2006 | US7025967 Recombinant protein production in bovine adenovirus expression vector system |
| 04/11/2006 | US7025964 Peptide-based immunotherapeutic agent |
| 04/11/2006 | US7025963 Vaccine against Gram-negative bacterial infections |
| 04/11/2006 | US7025962 Gene encoding lymphocyte surface antigen; protein or nucleic acid |
| 04/11/2006 | US7025961 Anti-plasmodium composition and methods of use |
| 04/11/2006 | US7025959 Drug containing Dna coding of protein; hybrids; genetic engineering |
| 04/06/2006 | WO2006037070A2 Stabilization of alum-adjuvanted immunologically active agents |
| 04/06/2006 | WO2006037038A1 Optimized vaccines to provide protection against ebola and other viruses |
| 04/06/2006 | WO2006037029A2 Methods for treating conditions associated with the accumulation of excess extracellular matrix |
| 04/06/2006 | WO2006036817A2 Fungal variants and uses thereof |
| 04/06/2006 | WO2006036745A2 Il-23p40 specific immunoglobulin derived proteins, compositions, epitopes, methods and uses |
| 04/06/2006 | WO2006036568A2 Antibody buffering of a ligand in vivo |
| 04/06/2006 | WO2006036550A2 Listeria-based and llo-based vaccines |
| 04/06/2006 | WO2006036371A2 Combination therapy |
| 04/06/2006 | WO2006036233A1 West nile viruses with mutations in the 3’ terminal stem and loop secondary structure for use as live virus vaccines |
| 04/06/2006 | WO2006036213A2 The use of gammaglobulin for the treatment of periodontal disease |
| 04/06/2006 | WO2006036202A2 Stabilized biodegradable neurotoxin implants |
| 04/06/2006 | WO2006035979A1 Functional composition or food containing whey protein, antibody derived from milk, or antibody |
| 04/06/2006 | WO2006035815A1 Method of producing partial peptide of enolase protein from plasmodium falciparum |
| 04/06/2006 | WO2006035681A1 HLA-A11-RESTRICTED Tax ANTITUMOR EPITOPES |
| 04/06/2006 | WO2006035311A2 GROUP A STREPTOCOCCUS CrgE PROTEIN |
| 04/06/2006 | WO2006035225A1 Clostridial neurotoxins for use in tissue healing |
| 04/06/2006 | WO2006035082A1 Mutant g genes of the trout viral haemorrhagic septicaemia virus (vhsv) and applications thereof |
| 04/06/2006 | WO2006034707A1 Liquid allergy vaccine formulation for oromucosal administration |
| 04/06/2006 | WO2006034545A1 Variants of hepatitis b virus with resistance to anti-viral nucleoside agents and applications thereof |
| 04/06/2006 | WO2006026470A3 Hiv immunostimulatory compositions |
| 04/06/2006 | WO2006007555A3 Rotavirus antigens |
| 04/06/2006 | WO2005115452A9 Fcϝriib-specific antibodies and methods of use thereof |
| 04/06/2006 | WO2005115412A3 Compositions and methods for modulating an immune response |
| 04/06/2006 | WO2005097162A3 Steroid sparing agents and their use |
| 04/06/2006 | WO2005079755A3 Interleukin-13 antagonist powders, spray-dried particles, and methods |
| 04/06/2006 | WO2005062871A3 Tat linear epitope peptides and conjugates thereof for use in therapeutic compositions and assays |
| 04/06/2006 | WO2005053795A3 Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor |
| 04/06/2006 | WO2005026203A3 Dna promoters and anthrax vaccines |
| 04/06/2006 | WO2004093831A3 Cytokine-expressing cellular vaccine combinations |
| 04/06/2006 | WO2004076621A3 Compositions of nucleic acids for treating and detecting influenza virus |
| 04/06/2006 | WO2003045128A3 SYNTHETIC IMMUNOGENIC BUT NON-DEPOSIT-FORMING POLYPEPTIDES AND PEPTIDES HOMOLOGOUS TO AMYLOID β, PRION PROTEIN, AMYLIN, α-SYNUCLEIN, OR POLYGLUTAMINE REPEATS FOR INDUCTION OF AN IMMUNE RESPONSE THERETO |
| 04/06/2006 | US20060074377 Microprojection array immunization patch and method |
| 04/06/2006 | US20060074233 Detect binding with cells transfected with DNA |
| 04/06/2006 | US20060074226 Pro9835 antibodies |
| 04/06/2006 | US20060074119 Thiophene compounds |
| 04/06/2006 | US20060074038 Her-2 neu dna vaccine having anti-cancer activity |
| 04/06/2006 | US20060074022 Prevention of primary Sjogren's Syndrome by ICA69 deficiency |
| 04/06/2006 | US20060074009 Natriuretic compounds, conjugates, and uses thereof |
| 04/06/2006 | US20060073589 Rapid generation of activated mononuclear antigen presenting cells from monocytes |
| 04/06/2006 | US20060073576 envelope proteins (Env) comprising CD4 (and mimetics) binding site and deletion region; maintains structural conformation of complementary determining region 2-like loop; insertion near chemokine receptor binding site; vectors, cells; liposomes |
| 04/06/2006 | US20060073569 Protease for identifying modulators for treatment and prevention of thrombocytopenia and liver disorders |
| 04/06/2006 | US20060073567 Novel insulin/IGF/relaxin family polypeptides and DNAs thereof |
| 04/06/2006 | US20060073519 Antibody specific to interleukin 18 precursor |
| 04/06/2006 | US20060073477 Altered DNA synthesome components as biomarkers for malignancy |
| 04/06/2006 | US20060073333 Dispersing a matrix of nanostructured liquid phase or a dehydrated variant and a nanostructured liquid crystalline phase or a dehydrated variant in nonlamellar material; cooling or evaporating a volatile solvent |
| 04/06/2006 | US20060073208 Cosmetic neurotoxin compositions and methods |
| 04/06/2006 | US20060073197 Encapsulated transfer factor compositions and methods of use |
| 04/06/2006 | US20060073171 Vaccine composition against malaria |
| 04/06/2006 | US20060073170 Vaccine complex for preventing or treating leishmaniases |
| 04/06/2006 | US20060073169 Acellular antibordetella vaccine |
| 04/06/2006 | US20060073168 contacting an isolated serogroup A meningococcal capsular polysaccharide with an isolated Serogroup A Neisseria meningitidis O-acetyltransferase polypeptide; immunogenic compositions; vaccine for generating a protective immune response to Neisseria meningitidis |
| 04/06/2006 | US20060073167 Vaccine for fish cold-water disease |
| 04/06/2006 | US20060073166 ras-mediated; administering immunosuppressive for immune constituents that may interfere with the systemic delivery of the reovirus; antiproliferative; in the neoplastic cells phosphorylation of PKR is prevented by inactivation or deletion of PKR |
| 04/06/2006 | US20060073165 Vaccine against infectious agents having an intracellular phase, composition for the treatment and prevention of HIV infections, antibodies and method of diagnosis |
| 04/06/2006 | US20060073164 Dengue and West Nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications |
| 04/06/2006 | US20060073163 Anti-sepsis conjugate vaccine |
| 04/06/2006 | US20060073161 Nucleic acid and amino acid sequences relating to Bacteroides fragilis for diagnostics and therapeutics |
| 04/06/2006 | US20060073160 Cloning of chicken anemia virus DNA |
| 04/06/2006 | US20060073159 Human anti-cancer immunotherapy |
| 04/06/2006 | US20060073158 Methods and compositions comprising supramolecular constructs |
| 04/06/2006 | US20060073157 Attenuated live Neospora vaccine |
| 04/06/2006 | US20060073156 Fosfomycin and n-acetylcysteine for the treatment of biofilms caused by escheric ia coli and other pathogens of the urinary tract |
| 04/06/2006 | US20060073155 Methods and compositions for diseases associated with amyloidosis |
| 04/06/2006 | US20060073154 Group a streptococci bind to mucin and human pharyngeal cells through a sialic acid-containing receptor |
| 04/06/2006 | US20060073153 Individualized anti-cancer antibodies |
| 04/06/2006 | US20060073152 Therapeutic agents with decreased toxicity |